Skip to main content
logo
Strides Pharma Science Limited (NSE:STAR)
India flag India · Delayed Price · Currency is INR
796.25
-68.35 (-7.91%)
At close: Jan 23, 2026

Strides Pharma Science Revenue

Strides Pharma Science had revenue of 12.21B INR in the quarter ending September 30, 2025, with 1.64% growth. This brings the company's revenue in the last twelve months to 46.85B, up 6.22% year-over-year. In the fiscal year ending March 31, 2025, Strides Pharma Science had annual revenue of 45.65B with 17.36% growth.

Revenue (ttm)
46.85B
Revenue Growth
+6.22%
P/S Ratio
1.57
Revenue / Employee
14.19M
Employees
3,301
Market Cap
73.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202545.65B6.75B17.36%
Mar 31, 202438.90B2.02B5.47%
Mar 31, 202336.88B6.18B20.13%
Mar 31, 202230.70B-2.46B-7.41%
Mar 31, 202133.16B5.64B20.49%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Alembic Pharmaceuticals70.83B
NATCO Pharma43.90B
Akums Drugs and Pharmaceuticals41.10B
Eris Lifesciences29.86B
Alivus Life Sciences25.12B
Aarti Pharmalabs19.06B
Innova Captab14.94B
Cohance Lifesciences12.11B
Revenue Rankings

Strides Pharma Science News

More News